2.2 Eligibility criteria and relevant outcomes Studies which answered the most important question (regarding the efficacy and safety of subcutaneous semaglutide treatment on weight loss) and report the experiences of adults (age 18 years) with overweight or obese (BMI 25kg/m 2 ) who were prescribed semaglutide treatment for weight management in randomized controlled trials were included
The hair shedding usually starts about 3 months after rapid weight loss, and hair regrowth is noticeable 6 to 9 months later once the body adjusts
When initiating GLP-1 therapy, patients should be aware of potential side effects
Also, GLP-1 RA seems to regulate glucose homeostasis by exhibiting glucagonostatic effects meaning suppression of glucagon by acting on pancreatic cells, which in turn reduce hepatic production of glucose (52)
For patients treating obesity or managing a weight-related condition, sustainable habits play a major role in long-term success
Despite a lack of direct interaction data between Lexapro and Wegovy, the implications of concurrent use warrant attention